These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 13907113)

  • 1. [The influence of nicotinic acid on brain circulation and brain metabolism in cerebral scleroses and other diffuse circulatory disorders of the brain. Quantitative measurements using the nitrous oxide method].
    HEYCK H
    Schweiz Med Wochenschr; 1962 Feb; 92():226-31. PubMed ID: 13907113
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of nicotinic acid on the cerebral circulation, with observations on extra-cerebral contamination of cerebral venous blood in the nitrous oxide procedure for cerebral blood flow.
    SCHEINBERG P
    Circulation; 1950 May; 1(5):1148-54. PubMed ID: 15411737
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cerebral blood flow, cerebral metabolism and effect of therapy in cerebral syphilis. Quantitative measurement by the nitrous oxide method].
    HEYCK H
    Psychiatr Neurol (Basel); 1962; 143():260-73. PubMed ID: 13907105
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of nicotinic acid amide and sodium on glycolysis and oxygen uptake in brain homogenates.
    RACKER E; KRIMSKY I
    J Biol Chem; 1945 Dec; 161():453-61. PubMed ID: 21006928
    [No Abstract]   [Full Text] [Related]  

  • 5. [Results in therapy of essential hypertension and cerebral sclerosis with mutan].
    SKURSKY J
    Wien Med Wochenschr; 1953 Jan; 103(5):108. PubMed ID: 13078445
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative in vitro study of guinea pig brain oxidations as influenced by xenon and nitrous oxide.
    PITTINGER CB; FEATHERSTONE RM; CULLEN SC; GROSS EG
    J Lab Clin Med; 1951 Sep; 38(3):384-7. PubMed ID: 14880751
    [No Abstract]   [Full Text] [Related]  

  • 7. [On the treatment of cerebral sclerosis with complamine].
    KESSENS L
    Med Welt; 1960 Nov; 47():2517-8. PubMed ID: 13752735
    [No Abstract]   [Full Text] [Related]  

  • 8. [Administration of nicotinic acid in cerebral circulatory disorders, especially in states following apoplexy with hemiplegia].
    MENTHA J; STEPONAVICIUS J
    Helv Med Acta; 1951 Dec; 18(6):608-31. PubMed ID: 14897342
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical studies of the nitrous oxide method for determination of the cerebral blood flow in the diagnosis of cerebral vascular processes].
    Becker K
    Med Klin; 1970 Jul; 65(28):1323-7. PubMed ID: 5520708
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of subanesthetic dose of nitrous oxide on cerebral blood flow and metabolism: a multimodal magnetic resonance imaging study in healthy volunteers.
    Dashdorj N; Corrie K; Napolitano A; Petersen E; Mahajan RP; Auer DP
    Anesthesiology; 2013 Mar; 118(3):577-86. PubMed ID: 23324809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Research on the action of vasoactive drugs on cerebral circulation in patients suffering from apoplectic strokes. II. Action of nicotinic acid].
    SCIAGRA A; NUTI A
    Riv Crit Clin Med; 1959 Apr; 59():309-16. PubMed ID: 14444163
    [No Abstract]   [Full Text] [Related]  

  • 12. [Note on circulatory disorders caused by administration of isonicotinic acid hydrazide].
    LEIDENBERGER W
    Tuberkulosearzt; 1953 Mar; 7(3):141-2. PubMed ID: 13077778
    [No Abstract]   [Full Text] [Related]  

  • 13. [Anesthetic management of a patient with tuberous sclerosis].
    Sugi Y; Yasumoto M; Higa K; Dan K
    Masui; 1996 Feb; 45(2):227-9. PubMed ID: 8865713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of functional circulatory disorders].
    BIRKMAYER W
    Prakt Arzt; 1952 Oct; 6(65):598-603. PubMed ID: 13026690
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of nitrous oxide on local cerebral glucose utilization in rats.
    Ingvar M; Siesjö BK
    J Cereb Blood Flow Metab; 1982 Dec; 2(4):481-6. PubMed ID: 7142311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [ON THE TREATMENT OF CEREBRAL AND PERIPHERAL CIRCULATORY DISORDERS. (REPORT ON CLINICAL EXPERIENCES WITH COMPLAMIN)].
    LOOS M
    Med Welt; 1964 Aug; 32():1710-2. PubMed ID: 14291150
    [No Abstract]   [Full Text] [Related]  

  • 17. NEUROPATHOLOGICAL AND CHEMICAL ASPECTS OF DIFFUSE DEMYELINATING DISEASES.
    STAM FC
    Psychiatr Neurol Neurochir; 1964; 67():332-41. PubMed ID: 14207402
    [No Abstract]   [Full Text] [Related]  

  • 18. [EXTENDED THERAPEUTIC POSSIBILITIES IN PERIPHERAL CIRCULATORY DISORDERS WITH SPECIAL RESPECT TO FIBRINOLYSIS ACTIVATION].
    LUCZAK S
    Chirurg; 1964 Dec; 35():546-8. PubMed ID: 14342271
    [No Abstract]   [Full Text] [Related]  

  • 19. The influence of nitrous oxide on the metabolic activity of brain tissue.
    HOSEIN EA; STACHIEWICZ E; BOURNE W; DENSTEDT OF
    Anesthesiology; 1955 Sep; 16(5):708-15. PubMed ID: 13249104
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cerebral sclerosis and its treatment with cosaldon].
    MEYER J
    Med Klin; 1957 Jun; 52(24):1073-4. PubMed ID: 13451071
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.